CancerVolume 72, Issue 6 p. 1809-1812 EditorialFree Access Mammography screening for breast cancer Daniel B. Kopans M.D., Corresponding Author Daniel B. Kopans M.D. Department of Radiology, Massachusetts General Hospital, Boston, MassachusettsDepartment of Radiology, Massachusetts General Hospital, Boston, MA 02114===Search for more papers by this author Daniel B. Kopans M.D., Corresponding Author Daniel B. Kopans M.D. Department of Radiology, Massachusetts General Hospital, Boston, MassachusettsDepartment of Radiology, Massachusetts General Hospital, Boston, MA 02114===Search for more papers by this author First published: 15 September 1993 https://doi.org/10.1002/1097-0142(19930915)72:6<1809::AID-CNCR2820720603>3.0.CO;2-DCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973– 8. 2 van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R. The current detectability of breast cancer in a mammographic screening program: a review of the previous mammograms of interval and screen-detected cancers. Cancer 1993; 72: 1933– 8. 3 Tabar L, Gad A, Holmberg L, Ljungquist U. Significant reduction in advanced breast cancer: results of the first seven years of mammography screening in Kopparberg, Sweden. Diag Imag Clin Med 1985; 54: 158– 64. 4 Yaffe MJ, Correction: Canada study [letter to the editor]. J Natl Cancer Inst 1993; 85: 94. 5 Muir BB, Kirkpatrick A, Roberts MM, Duffy SW. Oblique-view mammography: adequacy for screening. Radiology 1984; 151: 39– 41. 6 Moskowitz M, Breast cancer: age-specific growth rates and screening strategies. Radiology 1986; 161: 37– 41. 7 Tabar L, Faberberg G, Day NE, Holmberg L. What is the optimum interval between screening examinations?: an analysis based on the latest results of the Swedish Two-County Breast Cancer Screening Trial. Br J Cancer 1987; 55: 547– 51. 8 Tabar L, Fagerberg G, Duffy S, Day N, Gad A, Grontoft O. Update of the Swedish Two-County Program of Mammographic Screening for Breast Cancer. Rad Clin North Am 1992; 30: 187– 210. 9 Bird RE, Professional quality assurance for mammographic screening programs. Radiology 1990; 177: 587. 10 Bassett LW, Liu TH, Giuliano ARE, Gold RH. The prevalence of carcinoma in palpable vs impalpable mammographically detected lesions. AJR 1991; 157: 21– 4. 11 Sickles EA, Mammographic features of 300 consecutive nonpalpable breast cancers. AJR 1986; 146: 661– 3. 12 D'Orsi CJ, To follow or not to follow, that is the question. Radiology 1992; 184: 306. 13 Gallagher WJ, Cardenosa G, Rubens JR, McCarthy KA, Kopans DB. Minimal-volume excision of nonpalpable breast lesions AJR 1989; 153: 957– 61. 14 Azevado E, Svane G, Auer G. Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet 1989; 1: 1033– 6. Citing Literature Volume72, Issue615 September 1993Pages 1809-1812 ReferencesRelatedInformation